203 related articles for article (PubMed ID: 15500393)
1. Selective oestrogen receptor modulators in desmoid tumours.
Picariello L; Tonelli F; Brandi ML
Expert Opin Investig Drugs; 2004 Nov; 13(11):1457-68. PubMed ID: 15500393
[TBL] [Abstract][Full Text] [Related]
2. The search for the ideal SERM.
Arun B; Anthony M; Dunn B
Expert Opin Pharmacother; 2002 Jun; 3(6):681-91. PubMed ID: 12036407
[TBL] [Abstract][Full Text] [Related]
3. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
Thiebaud D; Secrest RJ
Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
[TBL] [Abstract][Full Text] [Related]
4. A pharmacological review of selective oestrogen receptor modulators.
Goldstein SR; Siddhanti S; Ciaccia AV; Plouffe L
Hum Reprod Update; 2000; 6(3):212-24. PubMed ID: 10874566
[TBL] [Abstract][Full Text] [Related]
5. Selective oestrogen receptor modulators.
Burger HG
Horm Res; 2000; 53 Suppl 3():25-9. PubMed ID: 10971099
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects.
Muchmore DB
Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
Park WC; Jordan VC
Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
[TBL] [Abstract][Full Text] [Related]
8. Skeletal effects of selective oestrogen receptor modulators (SERMs).
Díez JL
Hum Reprod Update; 2000; 6(3):255-8. PubMed ID: 10874570
[TBL] [Abstract][Full Text] [Related]
9. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Musa MA; Khan MO; Cooperwood JS
Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
[TBL] [Abstract][Full Text] [Related]
10. Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene.
Tonelli F; Ficari F; Valanzano R; Brandi ML
Tumori; 2003; 89(4):391-6. PubMed ID: 14606641
[TBL] [Abstract][Full Text] [Related]
11. Selective oestrogen receptor modulators--current and future brain and behaviour applications.
Halbreich U; Kahn LS
Expert Opin Pharmacother; 2000 Dec; 1(7):1385-98. PubMed ID: 11249472
[TBL] [Abstract][Full Text] [Related]
12. Beyond raloxifene for the prevention of osteoporosis and breast cancer.
Jordan VC
Br J Pharmacol; 2007 Jan; 150(1):3-4. PubMed ID: 17115068
[TBL] [Abstract][Full Text] [Related]
13. [Selective estrogen receptor modulators (SERMs)].
Chaki O
Nihon Rinsho; 2015 Oct; 73(10):1673-81. PubMed ID: 26529929
[TBL] [Abstract][Full Text] [Related]
14. Novel agents to modulate oestrogen action.
Dardes RC; Jordan VC
Br Med Bull; 2000; 56(3):773-86. PubMed ID: 11255561
[TBL] [Abstract][Full Text] [Related]
15. [Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
Hart W; Netelenbos JC
Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1771-6. PubMed ID: 10494328
[TBL] [Abstract][Full Text] [Related]
16. The selective oestrogen receptor modulators idoxifene and raloxifene have fundamentally different cell-specific oestrogen-response element (ERE)-dependent/independent mechanisms in vitro.
Nuttall ME; Fisher PW; Suva LJ; Gowen M
Eur J Cancer; 2000 Sep; 36 Suppl 4():S63-4. PubMed ID: 11056323
[TBL] [Abstract][Full Text] [Related]
17. Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134).
Ning M; Zhou C; Weng J; Zhang S; Chen D; Yang C; Wang H; Ren J; Zhou L; Jin C; Wang MW
Br J Pharmacol; 2007 Jan; 150(1):19-28. PubMed ID: 17115070
[TBL] [Abstract][Full Text] [Related]
18. Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.
McIntosh JG; Minshall J; Saya S; Bickerstaffe A; Hewabandu N; Qama A; Emery JD
Br J Gen Pract; 2019 Dec; 69(689):e836-e842. PubMed ID: 31636127
[TBL] [Abstract][Full Text] [Related]
19. Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Cerrato F; Fernández-Suárez ME; Alonso R; Alonso M; Vázquez C; Pastor O; Mata P; Lasunción MA; Gómez-Coronado D
Br J Pharmacol; 2015 Mar; 172(5):1379-94. PubMed ID: 25395200
[TBL] [Abstract][Full Text] [Related]
20. The endometrial effects of SERMs.
Cano A; Hermenegildo C
Hum Reprod Update; 2000; 6(3):244-54. PubMed ID: 10874569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
